Pregabalin vs placebo
Treatment‐related adverse effects · adults and children with sickle cell disease experiencing neuropathic pain
It is very uncertain whether summary of findings ‐ Pharmacological intervention (pregabalin) changes treatment‐related adverse effects compared with placebo (very low certainty).
1 finding from 1 review
- Interventions for treating neuropathic pain in people with sickle cell disease 2019 · Cochrane Headline outcomes onlyRR 1.331 study · 22 participantsVery low